Heart failure drug withdrawal trial seeks safer treatment plans

NCT ID NCT07489547

Recruiting now Knowledge-focused Sponsor: Hospital de Clinicas de Porto Alegre Source: ClinicalTrials.gov ↗

First seen Apr 10, 2026 · Last updated May 21, 2026 · Updated 9 times

Summary

This study looks at whether people with stable heart failure whose heart function has improved can safely stop taking a type of medication called a mineralocorticoid antagonist (MRA). Researchers will compare those who stop the drug (taking a placebo instead) with those who continue it, monitoring heart function and blood markers over 24 weeks. The goal is to see if stopping the drug leads to any worsening of heart health. The study involves 90 adults with stable heart failure and improved heart pumping ability.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hospital de Clínicas de Porto Alegre
RECRUITING

Porto Alegre, Rio Grande do Sul, Brazil

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HEART FAILURE